Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved

Journal of Medical Microbiology

Volumn 61, Issue PART12, 2012, Pages 1719-1726

  Hwang, In sok ^a   Hwang, Ji Hong ^a   Choi, Hyemin ^a   Kim, Keuk Jun ^b   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

^b TaeKyeung University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; ADENOSINE TRIPHOSPHATE; AMPICILLIN; ANTIBIOTIC AGENT; BACTERICIDE; CHLORAMPHENICOL; HYDROXYL RADICAL; KANAMYCIN; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BIOFILM; CHRONIC DISEASE; DRUG POTENTIATION; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS; TISSUE CULTURE;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG SYNERGISM; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; SILVER; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS;

EID: 84869447824     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.047100-0     Document Type: Article

References (39)

1. Archer, G. L. (1998). Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 26, 1179-1181.
2. Atiyeh, B. S., Costagliola, M., Hayek, S. N. & Dibo, S. A. (2007). Effect of silver on burn wound infection control and healing: review of the literature. Burns 33, 139-148.
3. Christensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M. & Beachey, E. H. (1985). Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22, 996-1006.
4. CLSI (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard M7-A6. Wayne, PA: Clinical and Laboratory Standards Institute.
5. CLSI (2005). Performance Standards for Antimicrobial Susceptibility Testing, Fifteenth Informational Supplement. Approved standard M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Costerton, J. W. (1999). Introduction to biofilm. Int J Antimicrob Agents 11, 217-221, discussion 237-239.
7. Costerton, J. W., Irvin, R. T. & Cheng, K. J. (1981). The bacterial glycocalyx in nature and disease. Annu Rev Microbiol 35, 299-324.
8. Eliopoulos, G. M. & Moellering, R. C. (1991). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 3rd edn, pp. 432-492. Edited by V. Lorian. Baltimore, MD: Williams & Wilkins.
9. Gonçalves, P. P., Meireles, S. M., Neves, P. & Vale, M. G. (1999). Synaptic vesicle Ca2+/H+ antiport: dependence on the proton electrochemical gradient. Brain Res Mol Brain Res 71, 178-184.
10. Gurunathan, S., Lee, K. J., Kalishwaralal, K., Sheikpranbabu, S., Vaidyanathan, R. & Eom, S. H. (2009). Antiangiogenic properties of silver nanoparticles. Biomaterials 30, 6341-6350.
11. Hojo, K., Nagaoka, S., Ohshima, T. & Maeda, N. (2009). Bacterial interactions in dental biofilm development. J Dent Res 88, 982-990.
12. Hwang, I.-S., Lee, J., Hwang, J. H., Kim, K.-J. & Lee, D. G. (2012). Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals. FEBS J 279, 1327-1338.
13. Jung, H. J. & Lee, D. G. (2008). Synergistic antibacterial effect between silybin and N, N9-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates. J Microbiol 46, 462-467.
14. Khardori, N. & Yassien, M. (1995). Biofilms in device-related infections. J Ind Microbiol 15, 141-147.
15. Kim, K.-J., Sung, W. S., Suh, B. K., Moon, S.-K., Choi, J.-S., Kim, J. G. & Lee, D. G. (2009). Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 22, 235-242.
16. Kim, J.-S., Heo, P., Yang, T.-J., Lee, K.-S., Jin, Y.-S., Kim, S.-K., Shin, D. & Kweon, D.-H. (2011). Bacterial persisters tolerate antibiotics by not producing hydroxyl radicals. Biochem Biophys Res Commun 413, 105-110.
17. Klasen, H. J. (2000). Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 26, 117-130.
18. Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. & Collins, J. J. (2007). A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810.
19. Lau, G. W., Hassett, D. J. & Britigan, B. E. (2005). Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol 13, 389-397.
20. Levy, S. B. (1992). Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 36, 695-703.
21. Li, P., Li, J., Wu, C., Wu, Q. & Li, J. (2005). Synergistic antibacterial effects of b-lactam antibiotic combined with silver nanoparticles. Nanotechnology 16, 1912-1917.
22. Linnett, P. E. & Beechey, R. B. (1979). Inhibitors of the ATP synthetase systems. Methods Enzymol 55, 472-518.
23. Lynch, S. V., Dixon, L., Benoit, M. R., Brodie, E. L., Keyhan, M. P., Hu, P., Ackerley, D. F., Andersen, G. L. & Matin, A. (2007). Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms. Antimicrob Agents Chemother 51, 3650-3658.
24. Monroe, D. (2007). Looking for chinks in the armor of bacterial biofilms. PLoS Biol 5, e307.
25. Nadworny, P. L., Wang, J., Tredget, E. E. & Burrell, R. E. (2008). Antiinflammatory activity of nanocrystalline silver in a porcine contact dermatitis model. Nanomedicine 4, 241-251.
26. Odds, F. C. (2003). Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52, 1.
27. Paju, S. & Scannapieco, F. A. (2007). Oral biofilms, periodontitis, and pulmonary infections. Oral Dis 13, 508-512.
28. Palmer, J. (2006). Bacterial biofilms in chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 196, 35-39.
29. Pankey, G. A. & Ashcraft, D. S. (2005). In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 49, 2959-2964.
30. Rogers, J. V., Parkinson, C. V., Choi, Y. W., Speshock, J. L. & Hussain, S. M. (2008). A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. Nanoscale Res Lett 3, 129-133.
31. Ruden, S., Hilpert, K., Berditsch, M., Wadhwani, P. & Ulrich, A. S. (2009). Synergistic interaction between silver nanoparticles and membrane-permeabilizing antimicrobial peptides. Antimicrob Agents Chemother 53, 3538-3540.
32. Ruparelia, J. P., Chatterjee, A. K., Duttagupta, S. P. & Mukherji, S. (2008). Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 4, 707-716.
33. Shrivastava, S., Bera, T., Roy, A., Singh, G., Ramachandrarao, P. & Dash, D. (2007). Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18, 225103-225112.
34. Sintubin, L., De Windt, W., Dick, J., Mast, J., van der Ha, D., Verstraete, W. & Boon, N. (2009). Lactic acid bacteria as reducing and capping agent for the fast and efficient production of silver nanoparticles. Appl Microbiol Biotechnol 84, 741-749.
35. Swallow, C. J., Grinstein, S. & Rotstein, O. D. (1990). A vacuolar type H+-ATPase regulates cytoplasmic pH in murine macrophages. J Biol Chem 265, 7645-7654.
36. Venkatesh, M., Rong, L., Raad, I. & Versalovic, J. (2009). Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol 58, 936-944.
37. Wagner, V. E. & Iglewski, B. H. (2008). P. aeruginosa biofilms in CF infection. Clin Rev Allergy Immunol 35, 124-134.
38. Wei, G. X., Campagna, A. N. & Bobek, L. A. (2006). Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 57, 1100-1109.
39. Weisblum, B. & Davies, J. (1968). Antibiotic inhibitors of the bacterial ribosome. Bacteriol Rev 32, 493-528.